Glycorex Transplantation AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was SEK 16.44 million compared to SEK 18.89 million a year ago. Revenue was SEK 18.49 million compared to SEK 19.05 million a year ago. Net loss was SEK 8.27 million compared to SEK 5.82 million a year ago. Basic loss per share from continuing operations was SEK 0.11 compared to SEK 0.08 a year ago.